Pre-order Enquiry
Request Free Sample
Global TMJ Disorders Market Research Report—Forecast till 2027
SKU ID : MRF-18045176 | Publishing Date : 10-Mar-2021 | No. of pages : 111
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global TMJ Disorders Market Research Report—Forecast till 2027
TABLE OF CONTENT1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 15
2.2 RESEARCH OBJECTIVE 15
2.3 MARKET STRUCTURE 15
2.4 ASSUMPTIONS & LIMITATIONS 16
3 RESEARCH METHODOLOGY
3.1 DATA MINING 17
3.2 SECONDARY RESEARCH 18
3.3 PRIMARY RESEARCH 19
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 GROWING RATES OF PET OWNERSHIP 26
4.2.2 RISING ZOONOTIC & CHRONIC DISEASES ANIMALS 26
4.2.3 INCREASING MEAT CONSUMPTION ATTRACTING MANDATORY VACCINATION 26
4.3 RESTRAINT 27
4.3.1 SHORTAGE OF VETERINARIANS 27
4.3.2 STRINGENT REGULATORY GUIDELINES PERTAINING TO VACCINES APPROVAL FOR ANIMALS 27
4.4 OPPORTUNITY 28
4.4.1 INCREASING INVESTMENT IN VETERINARY HOSPITALS 28
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 29
5.1.1 R&D 30
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION & SALES 30
5.1.4 POST-SALES REVIEW/MONITORING 30
5.2 PORTER'S FIVE FORCES MODEL 31
5.2.1 THREAT OF NEW ENTRANTS 31
5.2.2 BARGAINING POWER OF SUPPLIERS 32
5.2.3 THREAT OF SUBSTITUTES 32
5.2.4 BARGAINING POWER OF BUYERS 32
5.2.5 INTENSITY OF RIVALRY 32
5.3 IMPACT OF COVID-19 32
5.3.1 OVERVIEW 32
5.3.2 IMPACT ON MEAT CONSUMPTION 33
5.3.3 IMPACT ON VETERINARY MEDICINE MARKET 33
6 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
6.1 OVERVIEW 34
6.2 DOMESTICATED 35
6.3 COMPANION 35
7 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT
7.1 OVERVIEW 37
7.2 DRUG 38
7.3 VACCINES 39
8 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW 40
8.2 ORAL 41
8.3 PARENTERAL 41
8.4 OTHERS 42
9 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW 43
9.2 VETERINARY HOSPITALS & CLINICS 44
9.3 RETAIL STORES 44
9.4 ONLINE PHARMACIES 45
10 GLOBAL VETERINARY MEDICINE MARKET, BY REGION
10.1 OVERVIEW 46
10.2 AMERICAS 48
10.2.1 NORTH AMERICA 50
10.2.1.1 US 52
10.2.1.2 CANADA 53
10.2.2 LATIN AMERICA 54
10.3 EUROPE 56
10.3.1 WESTERN EUROPE 58
10.3.1.1 GERMANY 60
10.3.1.2 UK 61
10.3.1.3 FRANCE 62
10.3.1.4 ITALY 63
10.3.1.5 SPAIN 64
10.3.1.6 REST OF WESTERN EUROPE 65
10.3.2 EASTERN EUROPE 67
10.4 ASIA-PACIFIC 69
10.4.1 CHINA 71
10.4.2 JAPAN 72
10.4.3 INDIA 73
10.4.4 AUSTRALIA 74
10.4.5 SOUTH KOREA 75
10.4.6 REST OF ASIA-PACIFIC 76
10.5 MIDDLE EAST & AFRICA 78
10.5.1 SAUDI ARABIA 80
10.5.2 UNITED ARAB EMIRATES 81
10.5.3 OMAN 83
10.5.4 KUWAIT 84
10.5.5 QATAR 85
10.5.6 REST OF THE MIDDLE EAST & AFRICA 86
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 88
11.2 COMPETITIVE BENCHMARKING 89
11.3 GLOBAL VETERINARY MEDICINE MARKET: COMPANY RANKING 90
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 91
11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY MEDICINE MARKET 91
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 92
11.6.1 NEW PRODUCT LAUNCHES 92
11.6.2 PARTNERSHIPS/AGREEMENTS 92
11.6.3 EXPANSIONS 93
11.6.4 ACQUISITIONS 93
11.7 FINANCIAL MATRIX 94
12 COMPANY PROFILES
12.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 96
12.1.1 COMPANY OVERVIEW 96
12.1.2 FINANCIAL OVERVIEW 97
12.1.3 PRODUCTS/SERVICES OFFERED 97
12.1.4 KEY DEVELOPMENTS 99
12.1.5 SWOT ANALYSIS 99
12.1.6 KEY STRATEGIES 100
12.2 CEVA 101
12.2.1 COMPANY OVERVIEW 101
12.2.2 FINANCIAL OVERVIEW 101
12.2.3 PRODUCTS/SERVICES OFFERED 102
12.2.4 KEY DEVELOPMENTS 102
12.2.5 SWOT ANALYSIS 103
12.2.6 KEY STRATEGIES 103
12.3 ZOETIS 104
12.3.1 COMPANY OVERVIEW 104
12.3.2 FINANCIAL OVERVIEW 104
12.3.3 PRODUCTS/SERVICES OFFERED 105
12.3.4 KEY DEVELOPMENTS 107
12.3.5 SWOT ANALYSIS 107
12.3.6 KEY STRATEGIES 107
12.4 MERCK ANIMAL HEALTH 108
12.4.1 COMPANY OVERVIEW 108
12.4.2 FINANCIAL OVERVIEW 109
12.4.3 PRODUCTS/SERVICES OFFERED 110
12.4.4 KEY DEVELOPMENTS 111
12.4.5 SWOT ANALYSIS 112
12.4.6 KEY STRATEGIES 112
12.5 CHANELLE PHARMA GROUP 113
12.5.1 COMPANY OVERVIEW 113
12.5.2 FINANCIAL OVERVIEW 113
12.5.3 PRODUCTS/SERVICES OFFERED 113
12.5.4 KEY DEVELOPMENTS 115
12.5.5 SWOT ANALYSIS 115
12.5.6 KEY STRATEGIES 115
12.6 ELANCO 116
12.6.1 COMPANY OVERVIEW 116
12.6.2 FINANCIAL OVERVIEW 117
12.6.3 PRODUCTS/SERVICES OFFERED 118
12.6.4 KEY DEVELOPMENTS 119
12.6.5 SWOT ANALYSIS 120
12.6.6 KEY STRATEGIES 120
12.7 DECHRA PHARMACEUTICALS PLC 121
12.7.1 COMPANY OVERVIEW 121
12.7.2 FINANCIAL OVERVIEW 121
12.7.3 PRODUCTS/SERVICES OFFERED 122
12.7.4 KEY DEVELOPMENTS 123
12.7.5 SWOT ANALYSIS 123
12.7.6 KEY STRATEGIES 123
12.8 BAYER AG 124
12.8.1 COMPANY OVERVIEW 124
12.8.2 FINANCIAL OVERVIEW 124
12.8.3 PRODUCTS/SERVICES OFFERED 125
12.8.4 KEY DEVELOPMENTS 126
12.8.5 SWOT ANALYSIS 127
12.8.6 KEY STRATEGIES 127
12.9 VETOQUINOL SA. 128
12.9.1 COMPANY OVERVIEW 128
12.9.2 FINANCIAL OVERVIEW 128
12.9.3 PRODUCTS/SERVICES OFFERED 129
12.9.4 KEY DEVELOPMENTS 131
12.9.5 SWOT ANALYSIS 132
12.9.6 KEY STRATEGIES 132
12.10 NORBROOK LABORATORIES 133
12.10.1 COMPANY OVERVIEW 133
12.10.2 FINANCIAL OVERVIEW 133
12.10.3 PRODUCTS/SERVICES OFFERED 133
12.10.4 KEY DEVELOPMENTS 135
12.10.5 SWOT ANALYSIS 135
12.10.6 KEY STRATEGIES 136
13 APPENDIX
13.1 REFERENCES 137
13.2 RELATED REPORTS 138
List of Figures, Tables and Charts Available in Global TMJ Disorders Market Research Report—Forecast till 2027
LIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15
TABLE 2 US EPIDEMIOLOGY DATA 33
TABLE 3 GLOBAL TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 35
TABLE 4 GLOBAL TMJ DISORDERS MARKET, FOR MYOFASCIAL PAIN, BY REGION, 2017-2027 (USD MILLION) 35
TABLE 5 GLOBAL TMJ DISORDERS MARKET, FOR INTERNAL DERANGEMENT, BY REGION, 2017-2027 (USD MILLION) 36
TABLE 6 GLOBAL TMJ DISORDERS MARKET, FOR ARTHRITIS, BY REGION, 2017-2027 (USD MILLION) 36
TABLE 7 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 38
TABLE 8 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY REGION, 2017-2027 (USD MILLION) 38
TABLE 9 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 39
TABLE 10 GLOBAL TMJ DISORDERS MARKET, FOR THERAPY, BY REGION, 2017-2027 (USD MILLION) 39
TABLE 11 GLOBAL TMJ DISORDERS MARKET, FOR SURGICAL TREATMENT, BY REGION, 2017-2027 (USD MILLION) 39
TABLE 12 GLOBAL TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 41
TABLE 13 GLOBAL TMJ DISORDERS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2017-2027 (USD MILLION) 41
TABLE 14 GLOBAL TMJ DISORDERS MARKET, FOR AMBULATORY SURGERY CENTER, BY REGION, 2017-2027 (USD MILLION) 41
TABLE 15 GLOBAL TMJ DISORDERS MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2017-2027 (USD MILLION) 42
TABLE 16 GLOBAL TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION) 43
TABLE 17 AMERICAS: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION) 44
TABLE 18 AMERICAS: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 44
TABLE 19 AMERICAS: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 45
TABLE 20 AMERICAS: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 45
TABLE 21 AMERICAS: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 45
TABLE 22 NORTH AMERICA: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 46
TABLE 23 NORTH AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 46
TABLE 24 NORTH AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 47
TABLE 25 NORTH AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 47
TABLE 26 NORTH AMERICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 47
TABLE 27 US: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 48
TABLE 28 US: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 48
TABLE 29 US: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 48
TABLE 30 US: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 49
TABLE 31 CANADA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 49
TABLE 32 CANADA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 49
TABLE 33 CANADA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 50
TABLE 34 CANADA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 50
TABLE 35 LATIN AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 50
TABLE 36 LATIN AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 51
TABLE 37 LATIN AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 51
TABLE 38 LATIN AMERICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 51
TABLE 39 EUROPE: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION) 52
TABLE 40 EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 53
TABLE 41 EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 53
TABLE 42 EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 53
TABLE 43 EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 54
TABLE 44 WESTERN EUROPE: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 55
TABLE 45 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 55
TABLE 46 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 55
TABLE 47 WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 56
TABLE 48 WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 56
TABLE 49 GERMANY: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 56
TABLE 50 GERMANY: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 57
TABLE 51 GERMANY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 57
TABLE 52 GERMANY: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 57
TABLE 53 FRANCE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 58
TABLE 54 FRANCE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 58
TABLE 55 FRANCE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 58
TABLE 56 FRANCE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 59
TABLE 57 UK: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 59
TABLE 58 UK: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 59
TABLE 59 UK: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 60
TABLE 60 UK: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 60
TABLE 61 ITALY: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 60
TABLE 62 ITALY: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 61
TABLE 63 ITALY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 61
TABLE 64 ITALY: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 61
TABLE 65 SPAIN: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 62
TABLE 66 SPAIN: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 62
TABLE 67 SPAIN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 62
TABLE 68 SPAIN: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 63
TABLE 69 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 63
TABLE 70 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 63
TABLE 71 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 64
TABLE 72 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 64
TABLE 73 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 64
TABLE 74 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 65
TABLE 75 EASTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 65
TABLE 76 EASTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 65
TABLE 77 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 66
TABLE 78 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 67
TABLE 79 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 67
TABLE 80 ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 67
TABLE 81 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 68
TABLE 82 CHINA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 68
TABLE 83 CHINA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 68
TABLE 84 CHINA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 69
TABLE 85 CHINA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 69
TABLE 86 JAPAN: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 69
TABLE 87 JAPAN: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 70
TABLE 88 JAPAN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 70
TABLE 89 JAPAN: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 70
TABLE 90 INDIA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 71
TABLE 91 INDIA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 71
TABLE 92 INDIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 71
TABLE 93 INDIA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 72
TABLE 94 AUSTRALIA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 72
TABLE 95 AUSTRALIA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 72
TABLE 96 AUSTRALIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 73
TABLE 97 AUSTRALIA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 73
TABLE 98 SOUTH KOREA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 73
TABLE 99 SOUTH KOREA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 74
TABLE 100 SOUTH KOREA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 74
TABLE 101 SOUTH KOREA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 74
TABLE 102 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 75
TABLE 103 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 75
TABLE 104 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 75
TABLE 105 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 76
TABLE 106 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION) 77
TABLE 107 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 77
TABLE 108 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 78
TABLE 109 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 78
TABLE 110 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 78
TABLE 111 MIDDLE EAST: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 79
TABLE 112 MIDDLE EAST: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 79
TABLE 113 MIDDLE EAST: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 79
TABLE 114 MIDDLE EAST: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 80
TABLE 115 AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION) 80
TABLE 116 AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 80
TABLE 117 AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 81
TABLE 118 AFRICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION) 81
TABLE 119 GLOBAL TMJ DISORDERS COMPANY RANKING ANALYSIS (2019) 82
TABLE 120 AGREEMENT 84
TABLE 121 ACQUISITION 84
TABLE 122 EXPANSION 84
TABLE 123 LAUNCH & APPROVAL 84
TABLE 124 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 86
TABLE 125 SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS/SERVICES OFFERED 89
TABLE 126 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS/SERVICES OFFERED 92
TABLE 127 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED 94
TABLE 128 ALLERGAN: PRODUCTS/SERVICES OFFERED 96
TABLE 129 ALLERGAN: KEY DEVELOPMENTS 96
TABLE 130 BAYER AG.: PRODUCTS/SERVICES OFFERED 99
TABLE 131 ZYDUS CADILA: PRODUCTS/SERVICES OFFERED 101
TABLE 132 MYLAN NV: PRODUCTS/SERVICES OFFERED 103
TABLE 133 MYLAN NV: KEY DEVELOPMENTS 103
TABLE 134 NOVARTIS INTERNATIONAL AG: PRODUCTS/SERVICES OFFERED 106
TABLE 135 JUBILANT LIFE SCIENCES LIMITED: PRODUCTS/SERVICES OFFERED 109
Keyplayers in Global TMJ Disorders Market Research Report—Forecast till 2027
Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited
